Abstract:113 Purpose: For ischaemic stroke, thrombolysis is usually be chosen to improve the clinical outcome, however the induced reperfusion injury is a potential factor of poorer recovery. Oxidative stress is one factor which can leading to cell damage and death via reactive oxygen species (ROS) thus antioxidant strategies have been used in the treatment of stroke. In this study, Fe-GA coordination polymer nanoparticles (Fe-GA NCPs) were developed for an antioxidative neuroprotector in the ischemia stroke rat model and evaluated using PET/MR imaging. Methods: The ultra-small Fe-GA NCPs were synthesized and tested by transmission electric microscope (TEM) and dynamic light scattering. Their antioxidative effect were further evaluated by the degradation of methylene blue (MB), the coloration of tetramethylbenzidine (TMB), the reduction of 1,1-diphenyl-2-picrylhydrazyl (DPPH) and the electron spin resonance (ESR) spectroscopy in vitro. To investigate the neuroprotective effects of Fe-GA NCPs nanoparticles in vivo, we induced ischemic stroke in rats and subsequently injection before reperfusion which mimicked the pathologic process in clinic. Adult Sprague-Dawley male rats were performed middle cerebral artery occlusion (MCAO), and reperfusion was performed 90 min after MCAO. Fe-GA encephalic injection was performed 1h before reperfusion under standard operation. 24 h after reperfusion, all rats underwent neurologic testing followed by neurologic function scale, 18F-FDG small animal PET (Philips), PET/MR (Siemens) scanning, 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxylin-eosin (HE) staining and oxidative stress testing. Normal, sham operation, MCAO only, saline (NS), and edaravone were performed as control groups and evaluated as well. Results: Fe-GA NCPs were synthesized using a simple chemical process. TEM images revealed discrete and uniform 7 nm-sized nanoparticles. As proved by MB, TMB, DPPH, and ESR spectroscopy, the ultra-small Fe-GA NCPs could significantly scavenge the reactive oxygen/nitrogen species. After treated with Fe-GA NCPs, the neurological score was better than other control groups. For MCAO model, 18F-FDG PET/MR could show the low FDG uptake in the region of brain infarct and high signal in T2-weighted MRI imaging. We found that brain infarct volumes in rats treated with Fe-GA NCPs decreases significantly than other negative groups. Its therapeutic effect was even better than same concentration of edaravone which is used in clinic for same purpose. Further, TTC staining verified these in vivo imaging results. The areas of infarct lesion showed by PET/MRI were correlated with TTC staining results, suggesting PET/MRI could be effectively used for evaluation. HE staining also showed the shape and structure of infarct brain were abnormal. Finally, oxidative stress was tested for oblated brain tissue and found less ROS level in Fe-GA NCPs treated rats. Conclusions: Fe-GA CPNs exhibit an impressive antioxidative neuroprotective role in ischemia stroke, which might have the potential to be translated into clinical applications for improved treatment of patients with stroke. PET/MRI is effective and accurate method for ischemic evaluation.

ROS-responsive 18β-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Thrombus inhibition and neuroprotection for ischemic stroke treatment through platelet regulation and ROS scavenging

Selective Ischemic-Hemisphere Targeting Ginkgolide B Liposomes with Improved Solubility and Therapeutic Efficacy for Cerebral Ischemia-Reperfusion Injury

The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.

Targeted Therapy of Ischemic Stroke Via Crossing the Blood-Brain Barrier Using Edaravone-Loaded Multiresponsive Microgels.

ROS-scavenging Microgels Containing PTPσ Receptor Modulatory Peptides Synergistically Alleviate Inflammation and Promote Functional Recovery Post Stroke

Platelet Membrane-Encapsulated Ginkgolide B Biomimetic Nanoparticles for the Treatment of Ischemic Stroke

Neuroprotective Effect of Ganoderic Acid against Focal Ischemic Stroke Induced by Middle Cerebral Artery Occlusion in the Rats via Suppression of Oxidative Stress and Inflammation

Antioxidative Neuroprotective Role Of Iron-Gallic Acid Coordination Nanoparticles And Pet/Mr Usage In An Ischemia Stroke Model

Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels

Modulation of Abundance and Location of High-Mobility Group Box 1 in Human Microglia and Macrophages under Oxygen-Glucose Deprivation

Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery

Ultrasmall Iron‐gallic Acid Coordination Polymer Nanodots with Antioxidative Neuroprotection for PET/MR Imaging‐guided Ischemia Stroke Therapy

Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke

Curcumin loaded hydrogel with double ROS-scavenging effect regulates microglia polarization to promote poststroke rehabilitation

Macrophage‐Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke

Hypoxia-responsive Calixarene-Grafted Self-Assembled Peptide Hydrogel for Inflammation Suppression in Ischemic Stroke

Polydopamine-Cloaked Nanoarchitectonics of Prussian Blue Nanoparticles Promote Functional Recovery in Neonatal and Adult Ischemic Stroke Models

A neurovascular dual-targeting platelet-like bioinspired nanoplatform for ischemic stroke treatment

Effect of Tetrahedral Framework Nucleic Acids on Neurological Recovery via Ameliorating Apoptosis and Regulating the Activation and Polarization of Astrocytes in Ischemic Stroke